The content of this article is more than 5 years old. Please be aware that information provided may no longer be accurate, up-to-date, or relevant.
As organizer of an international germline editing summit, Prof. Alta Charo had a front row seat to the CRISPR babies controversy that unfolded last month in China. In her latest article for the New England Journal of Medicine, "Rogues and Regulation of Germline Editing," she calls for “a comprehensive ecosystem of public and private entities that can restrain the rogues among us.”
Charo's article has been cited in the following publications:
- "How to stop rogue gene-editing of human embryos?" New York Times, January 23, 2019.
- "How a rogue Chinese scientist sparked race to stop gene-editing of human embryos," The Australian Financial Review, January 23, 2019.
- "After CRISP babies, international medical leaders aim to tighten genome editing guidelines," STAT, January 24, 2019.
Submitted by Law School News on January 28, 2019
This article appears in the categories: In the Media
